Maternal Low-Level Lead Exposure and Fetal Growth by Zhu, Motao et al.
Faculty & Staff Scholarship 
2010 
Maternal Low-Level Lead Exposure and Fetal Growth 
Motao Zhu 
West Virginia University 
Edward F. Fitzgerald 
University of New York at Albany 
Kitty H. Gelberg 
New York State Department of Health 
Shao Lin 
New York State Department of Health 
Charlotte M. Druschel 
New York State Department of Health 
Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications 
Digital Commons Citation 
Zhu, Motao; Fitzgerald, Edward F.; Gelberg, Kitty H.; Lin, Shao; and Druschel, Charlotte M., "Maternal Low-
Level Lead Exposure and Fetal Growth" (2010). Faculty & Staff Scholarship. 2760. 
https://researchrepository.wvu.edu/faculty_publications/2760 
This Article is brought to you for free and open access by The Research Repository @ WVU. It has been accepted 
for inclusion in Faculty & Staff Scholarship by an authorized administrator of The Research Repository @ WVU. For 
more information, please contact ian.harmon@mail.wvu.edu. 
Environmental Health Perspectives • volume 118 | number 10 | October 2010 1471
Research | Children’s Health
With the banning of lead-based paint in 1977, 
and the phasing out of lead-based gasoline 
in the 1980s and its ban in 1996, the blood 
lead (PbB) concentration among the general 
U.S. population has been declining steadily 
[Centers for Disease Control and Prevention 
(CDC) 2005]. However, the general popu-
lation exposure to low lead levels continues 
because of the widespread use of lead and its 
ubiquitous nature (CDC 2005). According to 
the 2003–2004 National Health and Nutrition 
Examination Survey (CDC 2005), the mean 
PbB among women 18–49 years of age was 
1.2 µg/dL, with a 95th percentile of 2.6 µg/dL.
PbBs < 10 µg/dL induce adverse effects 
in humans, including elevated blood pres-
sure, impaired nervous system development, 
delayed sexual maturation, neurobehavioral 
effects, depressed renal glomerular filtration 
rate, and reduced heme synthesis [Agency 
for Toxic Substances and Disease Registry 
(ATSDR) 2007]. Furthermore, a clear thresh-
old for these sensitive effects has not been 
identified (ATSDR 2007). Maternal lead can 
readily cross the placenta and enter fetal blood 
circulation starting around week 12–14 of 
pregnancy, making the fetus susceptible to 
lead poisoning (Lin et al. 1998).
It is biologically plausible that lead can 
induce low birth weight, preterm birth, and 
small for gestational age. Lead can poten-
tially impair normal fetal bone growth by 
competing with calcium for deposition into 
bone because lead and calcium have simi-
lar chemical characteristics (Potula 2005). 
Experimental evidence provides support for 
a potential effect of lead on preterm birth. 
Lead impedes collagen synthesis and praline 
hydroxylation in mouse, which may have del-
eterious effects on chorioamniotic membrane 
structure and induce its premature rupture 
(Torres-Sanchez et al. 1999). Rats exposed 
to lead have reduced bone calcium content, 
reduced trabecular bone volume, altered 
growth plate morphology, and enhanced 
activities of spontaneous uterine contraction 
(Irgens 1998; Torres-Sanchez et al. 1999).
Limited epidemiologic studies have been 
conducted to examine maternal low-level 
lead exposure and fetal growth, especially 
using PbBs (Irgens 1998; Magri et al. 2003; 
Rothenberg et al. 2002; Sowers 2002; Torres-
Sanchez et al. 1999). Some studies included 
both low-level and high-level lead exposures, 
restricting the conclusions regarding low-level 
lead exposure alone (Torres-Sanchez et al. 
1999). Other studies are based on convenience 
samples such as prenatal clinic and Medicaid 
participants, limiting their generalizability 
(Sowers 2002).
Our study was designed to help address 
some of these issues, using a large population-
based PbB registry in New York state. The 
objectives were to examine whether maternal 
low-level PbB exposure (< 10 µg/dL) was 
inversely associated with birth weight and 
directly associated with the risk of preterm 
birth, and small for gestational age.
Methods
Study population and data sources. The 
study population comprised upstate New 
York (New York State, excluding New York 
City) mothers 15–49 years of age from 2003 
through 2005 who had a PbB test before or 
at the delivery date, and their singleton live 
births. PbBs were obtained from the New 
York State Heavy Metals Registry (HMR), 
which has maintained a statewide database 
since 1982 and receives reports on exposure 
to heavy metals, including lead, mercury, 
arsenic, and cadmium, from physicians and 
laboratories (New York State Department 
of Health Bureau of Occupational Health 
2008a). In 1992 the reporting requirement 
was changed from 25 µg/dL to include all 
test reports regardless of level (New York 
State Department of Health Bureau of 
Occupational Health 2008a). Information 
on birth outcomes and potential confounders 
was acquired from the birth certificate files, 
which are maintained by the New York State 
Department of Health, Bureau of Biometrics.
Study design and data linkage. A retro-
spective cohort design was used. The existing 
HMR records were linked with birth cer-
tificate files to form the study base. At first, 
women with multiple PbB reports were 
identified through deterministic matching 
techniques and transposed into one record 
containing information on all reporting dates 
and PbBs. To minimize the issues of data 
entry errors or missing values on identifiers, 
10 deterministic identifiers were created using 
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Background: Limited epidemiologic studies have examined the association between maternal 
low-level lead exposure [blood lead (PbB) < 10 µg/dL] and fetal growth.
oBjective: We examined whether maternal low-level lead exposure is associated with decreased 
fetal growth.
Methods: We linked New York State Heavy Metals Registry records of women who had PbB 
measurements with birth certificates to identify 43,288 mother–infant pairs in upstate New York 
in a retrospective cohort study from 2003 through 2005. We used multiple linear regression with 
fractional polynomials and logistic regression to relate birth weight, preterm delivery, and small for 
gestational age to PbB levels, adjusting for potential confounders. We used a closed-test procedure 
to identify the best fractional polynomials for PbB among 44 combinations.
results: We found a statistically significant association between PbB (square root transformed) and 
birth weight. Relative to 0 µg/dL, PbBs of 5 and 10 µg/dL were associated with an average of 61-g 
and 87-g decrease in birth weight, respectively. The adjusted odds ratio for PbBs between 3.1 and 
9.9 µg/dL (highest quartile) was 1.04 [95% confidence interval (CI), 0.89–1.22] for preterm deliv-
ery and 1.07 (95% CI, 0.93–1.23) for small for gestational age, relative to PbBs ≤ 1 µg/dL (lowest 
quartile). No clear dose–response trends were evident when all of the quartiles were assessed.
conclusions: Low-level PbB was associated with a small risk of decreased birth weight with a 
supralinear dose–response relationship, but was not related to preterm birth or small for gestational 
age. The results have important implications regarding maternal PbB.
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components from variables including the case 
number, social security number, date of birth, 
first name, last name, telephone number, ZIP 
code, street address, sex, and street address 
of the provider or physician ordering test. 
During each step, 50 matches were randomly 
selected and reviewed to ensure that the 
matches were accurate, using all the potential 
identifying variables: first name, last name, 
middle name, date of birth, street address, 
ZIP code, city, state, phone number, sex, 
street address, name of the provider or physi-
cian ordering test, and reporting laboratory 
identification number. A total of 215,426 
women 15–49 years of age were identified 
from 245,050 PbB tests that reported < 10 
µg/dL from 2003 through 2005.
PbB data were then matched with birth 
certificates to identify women who delivered 
live infants. Twenty deterministic identifiers 
were created using components from variables 
including date of birth, social security number, 
first name, middle name, last name, phone 
number, residential street, and ZIP code of the 
mother, and residential street and ZIP code 
of the father. A total of 44,932 singleton live 
births were identified with at least one PbB 
test by delivery and the maximal lead level 
< 10 µg/dL. We then excluded records with 
implausible birth weight–gestational age com-
binations (Alexander et al. 1996) to reduce the 
sample size to 44,873. Approximately 3.5% of 
mothers had multiple singleton births during 
the 3-year period, and we randomly selected 
one birth to finalize 43,288 mother–infant 
pairs. Approximately 3.0% of women received 
multiple PbB tests, so we similarly selected one 
test result at random.
This study was approved by the New York 
State Department of Health and the State 
University of New York at Albany institu-
tional review boards.
Study variables. Exposure. PbB concentra-
tion was obtained from the HMR PbB reports. 
The study level was restricted to < 10 µg/dL, 
which accounted for 99.2% of reports. Atomic 
spectrometry is the method for routine screen-
ing and diagnostic work (Parsons 1993). Its 
accuracy is ± 1 µg/dL and the detection limit 
is 1 µg/dL (Parsons 1993). Any errors in the 
measurement of PbB would be expected to be 
nondifferential according to low birth weight 
and other fetal growth outcomes. Laboratories 
are required to pass three of the quarterly pro-
ficiency tests every year by the New York State 
Department of Health, Wadsworth Center 
for Laboratories and Research, to ensure the 
accuracy and comparability (Lin et al. 1998). 
The coefficient of variation was approximately 
7% among all laboratories in 2005 (New 
York State Department of Health Wadsworth 
Center 2006).
Outcomes. Birth outcomes were abstracted 
from the birth certificate files. Only single-
ton live births were selected. Birth weight was 
examined as a continuous variable. Preterm 
birth was defined as the gestational age < 37 
completed weeks from the date of the last men-
strual period (March of Dimes Foundation 
2007). Small for gestational age was defined 
as the birth weight below the 10th percen-
tile of birth weight for gestational age based 
on the distribution of 1996–2000 national 
birth weight by gestational week from week 25 
through week 42 (Boulet et al. 2006). Binary 
low birth weight (< 2,500 g) was not examined 
in multiple variable analysis because continuous 
birth weight provides more statistical power 
to detect subtle effects. In addition, low birth 
weight is a mix of preterm, growth-restricted, 
and constitutionally small births; preterm birth 
and small for gestational age were examined in 
this study. Regarding the accuracy of outcomes 
recorded in New York State birth certificates, 
the dates of last menses reported in the birth 
certificate exactly agreed with those recorded in 
medical records for 87% (Roohan et al. 2003). 
The agreement rate was increased to 93% when 
the tolerance was 1 week (Roohan et al. 2003).
Confounders. In addition to the timing 
of lead test in relation to the date of delivery, 
various potential confounders were abstracted 
from the BC files: maternal race (Caucasian, 
African American, other); maternal ethnicity 
(Hispanic or not); maternal age at the time of 
delivery; maternal education (less than high 
school graduate, high school graduate, some 
college or college degree, graduate education); 
participation in financial assistance programs 
(e.g., Medicaid; Family Health Plus; Women, 
Infants, and Children; other) (yes or no); self-
reported maternal smoking during pregnancy 
(yes or no); self-reported maternal alcohol 
consumption during pregnancy (yes or no); 
self-reported illicit drug use during pregnancy 
(yes or no); trimester when prenatal care began 
(first trimester, second trimester, third trimes-
ter, or no prenatal care); parity (zero, one, two 
or more previous live births); sex of child; in 
wedlock (yes or no); and prepregnancy body 
mass index.
Statistical analysis. For continuous out-
comes (birth weight in grams and gestational 
age in days), we fitted multiple linear regres-
sion with fractional polynomials (Royston 
et al. 1999). We explored one or two terms of 
fractional polynomials in term of xp for PbB, 
where the power p is from –2, –1, –0.5, 1, 
2, 3, and natural logarithmic transformation. 
The selection of final fractional polynomials 
Table 1. Maternal and infant quantitative characteristics, upstate New York, 2003–2005.
Selected percentiles
Characteristic n Mean Minimum 10th 25th 50th 75th 90th Maximum
PbB (μg/dL) 43,288 2.1 0 1 1 2 3 3 9.9
Days from lead test to date of 
birth (day)
43,288 203 0 110 170 204 223 237 1,082
Maternal age (years) 43,288 27.6 15 20 23 27 32 36 49
Body mass index (kg/m2) 40,797 26.4 12.5 19.9 21.9 24.9 29.4 35.2 66.5
Gestational age (week) 43,288 38.8 20 37 38 39 40 41 44
Birth weight (g) 43,288 3,331 205 2,680 3,030 3,365 3,686 3,997 5,610
Table 2. Maternal and infant qualitative characteris-
tics, upstate New York, 2003–2005 (total n = 43,288).
Characteristic n Percentagea
Race
Caucasian 29,434 68.0
African American 7,113 16.5
Other 6,689 15.5
Missing value 52
Ethnicity
Hispanic 8,447 19.7
Missing value 492
Education
Less than high school graduate 10,054 23.4
High school graduate 11,675 27.2
Some college or bachelor degree 16,857 39.3
Graduate study 4,337 10.1
Missing value 365
Smoking
Yes 8,834 20.5
Missing value 149
Alcohol drinking
Yes 493 1.1
Missing value 196
Drug abuse
Yes 1,216 2.9
Missing value 973
Financial assistance program
Yes 25,803 59.8
Missing value 114
Start of prenatal care visit
First trimester 29,187 72.9
Second trimester 8,811 22.0
Third trimester or no prenatal 
care visit
2,056 5.1
Missing value 3,234
Parity
0 17,376 40.4
1 13,715 32.0
2 or more 11,823 27.6
Missing value 374
In wedlock
Yes 20,378 47.4
Missing value 261
Infant sex
Male 22,154 51.2
Low birth weight
Yes 2,744 6.3
Preterm birth
Yes 3,519 8.1
Small for gestational age
Yes 4,092 9.5
Missing value 112
aThe calculation of percentage excluded missing values. 
There were no missing values for infant sex, low birth 
weight, and preterm birth.
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was based on a closed-test procedure, which 
maintains the overall type 1 error (alpha level) 
of 0.05 for tests among 44 different com-
binations (Royston et al. 1999). For each 
outcome, a subset of biologically plausible 
risk factors in addition to PbB was selected 
to enter the model as potential confounders; 
those that remained with a significance level 
of 0.2 were retained (Dales and Urg 1978; 
Mickey and Greenland 1989; Royston et al. 
1999). Fractional polynomials were assessed 
for continuous confounders including gesta-
tional age and maternal age for birth weight 
outcome. Because the limit of detection for 
the routine screening and diagnostic labora-
tory method is 1 µg/dL (Parsons 1993), we 
conducted sensitivity analysis by a) compar-
ing all records; b) excluding PbBs of 0 µg/dL; 
c) excluding PbBs < 1 µg/dL.
Furthermore, the quartiles of PbBs 
(≤ 1 µg/dL; > 1 µg/dL to 2 µg/dL; > 2 µg/dL 
to 3 µg/dL; > 3 µg/dL to < 10 µg/dL) were 
used for binary outcomes including preterm 
birth and small for gestational age. Adjusted 
odds ratios (aORs) of PbBs were estimated 
from logistic regression with fractional poly-
nomials (Allison 1999; Royston et al. 1999). 
The quartiles of PbBs were forced into the 
model. A closed-test procedure was used to 
identify the 1 of 44 combinations of one 
or two fractional polynomials with the best 
model fit for continuous confounder: mater-
nal age. The criteria for selecting and retaining 
confounders in the logistic regression were 
similar to those for linear regression. Analyses 
were conducted using STATA version 11 
(StataCorp, College Station, TX, USA).
Results
The average PbB concentration was 2.1 µg/dL, 
and the median was 2 µg/dL (Table 1). The 
average number of days from lead test to deliv-
ery was 203, and the 90th percentile was 237. 
Most PbB tests were conducted between the 
date of last menses and the date of delivery. 
The average birth weight was 3,331 g, and ges-
tational age was 38.8 weeks. Table 2 presents 
the distribution of selected categorical mater-
nal and infant characteristics. Approximately 
68% of births were to white women, and 
Hispanics accounted for 20%. The rates of 
low birth weight, preterm birth, and small for 
gestational age were 6.3%, 8.1%, and 9.5%, 
respectively.
A model that assumed a linear relation 
between the square root of PbB and birth 
weight fit the data better than models with 
all other combinations of fractional polyno-
mial terms evaluated. Consequently, our final 
model included only a single term for PbB 
(raised to the 0.5 power), with an adjusted 
coefficient of –27.4 [95% confidence interval 
(CI), –37.7 to –17.1]. Estimated changes in 
birth weight with a 1-µg/dL change in PbB 
varied across the PbB distribution in the study 
population, consistent with the supralinear 
shape of the dose–response curve dictated by 
the model, so that a 1-µg/dL change in PbB 
from 0 µg/dL to 1 µg/dL was associated with a 
27.4-g decrease in mean birth weight, whereas 
a 1-µg/dL change in PbB from 9 µg/dL to 
10 µg/dL was associated with a 4.4-g decrease 
in mean birth weight (from a predicted mean 
decrease relative to predicted mean birth 
weight when PbB = 0 of 82.3 g to 86.7 g) 
(Table 3). Therefore, the model predicts the 
strongest estimated effects at the lowest  levels 
of exposure, without a lower threshold of PbB 
below which there would be no predicted 
effect on birth weight. Figure 1 displays this 
dose–response relationship.
As for sensitivity analysis, the best-fit 
fractional polynomials were PbB–1 + PbB–1 
× logarithmic-transformed PbB, after exclud-
ing PbB of 0 µg/dL from analysis (data not 
shown). Compared with PbB of 0.5 µg/dL, 
PbB of 9.5 µg/dL was associated with a 51-g 
decrease in birth weight. Compared with PbB 
of 1 µg/dL, PbB of 10 µg/dL was associated 
with a 32-g decrease in birth weight. When 
PbBs < 1 µg/dL were excluded, untransformed 
PbB fit the data the best, and the linear 
regression coefficient was a 7.0-g decrease in 
birth weight for a 1-µg/dL increase in PbB. 
Therefore, PbB of 10 µg/dL was associated 
with a 63-g decrease in birth weight, relative 
to PbB of 1 µg/dL. In contrast, the analysis 
using all PbBs including zeros and < 1 µg/dL 
suggested that PbB of 9.5 µg/dL was associ-
ated with an 84-g decrease in birth weight, 
relative to PbB of 0.5 µg/dL, and that PbB of 
10 µg/dL was associated with a 59-g decrease 
in birth weight, relative to PbB of 1 µg/dL. 
The analysis with all PbBs provided robust 
estimated effects of lead on birth weight.
A model that assumed a linear relation 
between untransformed PbB and gestational 
age in days fit the data better than models 
with all other combinations of fractional poly-
nomial terms evaluated. Consequently, our 
final model included only a single linear term 
for PbB, with an adjusted coefficient of –0.09 
(95% CI, –0.24 to 0.05) after adjustment for 
timing of lead test, maternal age, race, smok-
ing, alcohol consumption, participation in 
special financial assistance program, parity, 
and infant sex (data not shown).
Table 4 presents the association between 
the quartile PbBs and dichotomous outcomes: 
preterm birth and small for gestational age. 
There were not clear dose–response trends 
when all quartiles were assessed. The aORs 
for PbBs between 3.1 and 9.9 µg/dL (highest 
quartile) was 1.04 (95% CI, 0.89–1.22) for 
preterm birth and 1.07 (95% CI, 0.93–1.23) 
for small for gestational age, relative to 
≤ 1 µg/dL (lowest quartile).
Table 3. Association between PbB concentration 
and birth weight, upstate New York, 2003–2005.
PbB concentration 
(μg/dL)
Difference in birth weight 
in grams (model based)a
Estimate 95% CI
0 Reference
1 –27.4 –17.1 to –37.8
2 –38.8 –24.1 to –53.4
3 –47.5 –29.6 to –65.4
4 –54.8 –34.2 to –75.5
5 –61.3 –38.2 to –84.4
6 –67.2 –41.8 to –92.5
7 –72.5 –45.2 to –99.9
8 –77.6 –48.3 to –106.8
9 –82.3 –51.2 to –113.3
10 –86.7 –54.0 to –119.4
aThe model was a linear regression with fractional 
polynomials after adjustment for timing of lead test, 
gestational age, maternal age, race, Hispanic ethnic-
ity, education, smoking, alcohol drinking, drug abuse, 
in wedlock, participation in special financial assistant 
program, parity, and infant sex. PbB concentration was 
transformed using a square root. The coefficient was 
–27.4 with an SE of 5.3.
Figure 1. Model-based dose–response relationship.
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Table 4. Association between maternal PbB level and preterm birth, and small for gestational age, 
upstate New York, 2003–2005.
Maternal PbB level
Preterm birth Small for gestational age
Cases (n) aORa 95% CI Cases (n) aORb 95% CI
≤ 1.0 1,069 1.00 Reference 1,168 1.00 Reference
1.1–2.0 1,036 1.03 0.93–1.13 1,268 1.07 0.98–1.17
2.1–3.0 1,171 1.01 0.92–1.10 1,353 1.06 0.98–1.16
3.1–9.9 243 1.04 0.89–1.22 303 1.07 0.93–1.23
aaORs are estimated from logistic regression with fractional polynomials after adjustment for timing of lead test, 
maternal age at delivery, race, Hispanic ethnicity, smoking, drug abuse, in wedlock, participation in special financial 
assistance program, parity, and infant sex. The quartiles of PbB concentration were untransformed, and fractional 
polynomials were used for maternal age. baORs are estimated from logistic regression with fractional polynomials after 
adjustment for timing of lead test, maternal age at delivery, race, education, smoking, drug abuse, in wedlock, participa-
tion in special financial assistance program, parity, and infant sex. The quartiles of PbB concentration were untrans-
formed and fractional polynomials were assessed for maternal age.
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Discussion
Overall, maternal PbBs < 10 µg/dL were asso-
ciated with a small but statistically signifi-
cant decrease in birth weight. The decrease in 
birth weight for a 1-µg/dL increase in PbB 
ranged from an estimated means value of 4 g 
(from 9 to 10 µg/dL) to 27 g (from 0 to 1 µg/
dL). This is consistent with the estimate of 
a 6.2-g decrease in birth weight per 1-µg/dL 
increase in PbB from a study of 272 mother–
infant pairs in Mexico (Gonzalez-Cossio et al. 
1997); 3.0 g in a study of 4,354 pregnan-
cies in Boston (Bellinger et al. 1991); 0.8 g 
from a study of 54 term neonates in Turkey 
(Atabek et al. 2007); and 0.3 g in a study of 
55 newborns in Brazil (Zentner et al. 2006), 
despite that fact that their mean lead levels 
were higher than ours.
We found that a model of birth weight 
as a function of square root–transformed 
PbB provided the best fit to the data. This 
model predicted estimated effects of lead 
that were greater at the lower end of the PbB 
distribution than at higher levels (supralin-
ear dose–response relationship). A similar 
supralinear relationship has been reported 
for PbB < 10 µg/dL with IQ and Mental 
Development Index (Canfield et al. 2003; 
Lanphear et al. 2005; Tellez-Rojo et al. 
2006). A pooled analysis of seven interna-
tional prospective cohort studies found that 
the decrease in full-scale IQ score per 1-µg/
dL increase in PbB estimated from the lin-
ear regression with untransformed PbB was 
greater among children with a maximum PbB 
< 7.5 µg/dL than in those with a maximum 
PbB ≥ 7.5 µg/dL (Lanphear et al. 2005). 
Further analysis suggested a linear relation-
ship between the logarithmic-transformed 
PbB and IQ (coefficient: 6.9) (Lanphear et al. 
2005). An analysis of 294 children found a 
logarithmic-transformed PbB was linearly 
associated with Mental Development Index 
(Tellez-Rojo et al. 2006). The estimated effect 
of lead estimated from the linear regression 
with untransformed PbB was larger at < 5 
µg/dL than between 5 and 10 µg/dL (Tellez-
Rojo et al. 2006). Researchers have used 
quadratic term (Canfield et al. 2003) and 
logarithmic transformations (Lanphear et al. 
2005; Tellez-Rojo et al. 2006) to describe 
the supralinear relationship between lead and 
intellectual impairment. We found that the 
square root transformation provided the best 
fit for birth weight, compared with 43 other 
fractional polynomials linear, reciprocal, log-
arithmic, square foot, quadratic, and cubic 
terms. Further studies are needed to confirm 
whether the supralinear relationship between 
PbB and birth weight is best described with 
a square root transformation. Consistent 
with previous studies of intellectual develop-
ment (Canfield et al. 2003; Lanphear et al. 
2005; Tellez-Rojo et al. 2006), our analysis 
supports that there is no clear threshold for 
the effects of lead on sensitive outcomes such 
as birth weight.
Bellinger et al. reported that the mean ges-
tational age was 0.3 week longer among those 
with umbilical cord PbBs 5.0–9.9 µg/dL, 
relative to PbBs < 5.0 µg/dL (Bellinger et al. 
1991). In contrast, we found that a 1-µg/dL 
increase in maternal PbB was associated with 
a statistically nonsignificant 0.09-day decrease 
in gestational age. Similarly, Jelliffe-Pawlowski 
et al. reported that among women with PbB 
≥ 10 µg/dL, a 1-µg/dL increase in lead level 
was associated with an average 0.3-day decrease 
in gestational age (Jelliffe-Pawlowski et al. 
2006). In a case–control study of 620 preg-
nant women in Mexico City, compared with 
umbilical cord PbBs < 5.1 µg/dL, the aOR 
of preterm birth for lead level 5.1–9.0 µg/dL 
was 2.72 (95% CI, 1.03–7.19) among primi-
parous women, but 0.48 (95% CI, 0.21–1.08) 
among multi parous women (Torres-Sanchez 
et al. 1999).
Bellinger et al. found that lead levels 
between 5 and 9.9 µg/dL were not statistically 
related to increased risk in dichotomous pre-
term birth and small for gestational age, com-
pared with lead levels < 5 µg/dL (Bellinger 
et al. 1991). A cohort study by Sowers (2002) 
of 705 pregnant women in Camden, New 
Jersey, did not find any statistically significant 
association with dichotomous preterm birth, 
or small for gestational age. Consistent with 
their study, our study did not find statistically 
significant associations.
Jelliffe-Pawlowski et al. reported that 
women with PbBs ≥ 10 µg/dL were approxi-
mately three times as likely to experience a 
preterm delivery as women with lead levels 
< 10 µg/dL (aOR = 3.2; 95% CI, 1.2–7.4) and 
that their risk of having a small-for- gestational-
age infant was more than four times that of 
women with lead levels < 10 µg/dL (aOR = 
4.2; 95% CI, 1.3–13.9) (Jelliffe-Pawlowski 
et al. 2006). Chen et al. (2006), in a study of 
1,611 mother–infant pairs in Taiwan, China, 
suggested that maternal PbBs of ≥ 10 µg/dL 
were related to a doubling risk in low birth 
weight, preterm birth, and small for gesta-
tional age compared with maternal PbBs 
< 10 µg/dL. Highly elevated maternal PbBs 
would be expected to have adverse effects on 
fetal growth.
This study has multiple strengths. For 
example, we used PbBs to measure the 
absorbed dose circulated in the blood through 
various exposure routes and sources for preg-
nant women, which is more accurate than 
occupation history and other proxy exposure 
measures. By restricting the lead concentra-
tions to < 10 µg/dL, the associations between 
maternal lead level and fetal growth found 
in this study were not influenced by lead 
concentrations > 10 µg/dL, unlike previous 
studies that included lead concentrations 
below and > 10 µg/dL. Because this study was 
based on a statewide registry and the study 
lead concentration was close to the lead dis-
tribution among the general population, find-
ings should be more generalizable than those 
based on occupational settings or convenience 
samples. Furthermore, this study had a large 
sample size to detect subtle effects.
A possible limitation is selection bias. We 
found that the mothers in this study were 
younger and less likely to be Caucasian than 
other mothers in upstate New York. The link-
age rate of PbB reports with birth certificates 
was higher for mothers 18–19 years of age, 
African Americans, and with low-weight 
births, consistent with the selective screening 
for pregnant women at risk for adverse preg-
nancy outcome or lead exposure.
Dietary calcium and multiple vitamin use 
during pregnancy could not be controlled, 
as they were not collected on either the birth 
certificates or the HMR. Low dietary cal-
cium intake may increase the gastrointesti-
nal absorption of lead (Bogden et al. 1995). 
Calcium supplementation may reduce the 
lead mobilization from bone during preg-
nancy and therefore reduce the potential lead 
toxicity (Bellinger 2005; Han et al. 2000). 
Furthermore, residual confounding may exist 
because of the potential misclassification or 
categorization of confounders. For example, 
maternal smoking was recorded as “yes or no” 
in birth certificates. Its sensitivity was 89% 
and specificity was 99% using medical records 
as a gold standard (Roohan et al. 2003). There 
was no detailed information on the duration 
and frequency of smoking.
The results of this study have important 
implications regarding the recommended 
action level for childhood PbB. Although 
10 µg/dL is the current reference level set by 
the CDC (ATSDR 2007), this study suggests 
that maternal PbBs < 10 µg/dL may affect 
fetal growth. This issue is of public health sig-
nificance; in 2005, the HMR received about 
84,000 reports on women in New York state 
with PbBs < 10 µg/dL, and most of the reports 
were regarding women of reproductive age. 
Our study supports the continuation of lead 
screening during pregnancy, especially among 
women who are at risk because of current 
high-dose exposure, which is recommended 
by the New York State Department of Health 
(New York State Department of Health 
Bureau of Occupational Health 2008b). 
Conclusion
Among pregnant women whose PbB was 
< 10 µg/dL, PbB (square root transformed) 
was inversely associated with birth weight. 
Such findings suggest that the decrease in 
birth weight per 1-µg/dL increase in PbB was 
greater at lower concentrations than at higher 
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concentrations without evidence of a lower 
threshold of effect. These results are impor-
tant, given the high prevalence of low-level 
lead exposure among pregnant women and 
the controversy regarding the recommended 
action level for maternal PbB.
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